Comera Life Sciences (CMRAW) Competitors

$0.0008

0.00 (0.00%)

(As of 07/26/2024 ET)

Stock Analysis Chart Competitors Financials SEC Filings Trends

CMRAW vs. AEHAW, ALVOW, ACABW, SUBL, SAVAW, FBIOP, LIXTW, MYNZ, NLSPW, and NLSP

Should you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include Aesther Healthcare Acquisition (AEHAW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), BioLingus (Cayman) (SUBL), Cassava Sciences (SAVAW), Fortress Biotech (FBIOP), Lixte Biotechnology (LIXTW), Mainz Biomed (MYNZ), NLS Pharmaceutics (NLSPW), and NLS Pharmaceutics (NLSP). These companies are all part of the "pharmaceutical products" industry.

Comera Life Sciences vs.

Aesther Healthcare Acquisition (NASDAQ:AEHAW) and Comera Life Sciences (NASDAQ:CMRAW) are both manufacturing companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

: Company Net Margins Return on Equity Return on Assets
Aesther Healthcare Acquisition N/A N/A N/A
Comera Life Sciences N/A N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aesther Healthcare Acquisition N/A N/A N/A N/A N/A
Comera Life Sciences $1.00M N/A N/A N/A N/A
: Aesther Healthcare Acquisition and Comera Life Sciences both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
Aesther Healthcare Acquisition N/A N/A
Comera Life Sciences N/A N/A
: In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Aesther Healthcare Acquisition'saverage media sentiment score.
Company Overall Sentiment
Aesther Healthcare Acquisition Neutral
Comera Life Sciences Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aesther Healthcare Acquisition
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Comera Life Sciences
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A

Company	Net Margins	Return on Equity	Return on Assets
Aesther Healthcare Acquisition	N/A	N/A	N/A
Comera Life Sciences	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aesther Healthcare Acquisition	N/A	N/A	N/A	N/A	N/A
Comera Life Sciences	$1.00M	N/A	N/A	N/A	N/A

Company	Underperform	Outperform
Aesther Healthcare Acquisition	N/A	N/A
Comera Life Sciences	N/A	N/A

Company	Overall Sentiment
Aesther Healthcare Acquisition	Neutral
Comera Life Sciences	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aesther Healthcare Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Comera Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Comera Life Sciences beats Aesther Healthcare Acquisition on 1 of the 1 factors compared between the two stocks.

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Get Comera Life Sciences News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CMRAW vs. The Competition

Export to Excel

Metric	Comera Life Sciences	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$145.13M	$5.29B	$8.21B
Dividend Yield	N/A	3.49%	2.72%	3.97%
P/E Ratio	N/A	98.46	155.18	18.65
Price / Sales	N/A	17,014.92	2,087.66	91.84
Price / Cash	N/A	11.78	35.71	34.11
Price / Book	N/A	6.50	4.94	4.51
Net Income	N/A	-$19.02M	$111.73M	$216.36M
7 Day Performance	N/A	1.57%	2.74%	1.78%
1 Month Performance	N/A	5.71%	11.41%	7.92%
1 Year Performance	N/A	10.85%	10.02%	3.06%

Comera Life Sciences Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AEHAW Aesther Healthcare Acquisition	0 of 5 stars 0.00 / 5 stars	$0.04 flat	N/A	-76.4%	$0.00	N/A	0.00	2	Gap Up
ALVOW Alvotech	0 of 5 stars 0.00 / 5 stars	$2.68 flat	N/A	+70.4%	$0.00	$112.42M	0.00	4	Gap Up
ACABW Atlantic Coastal Acquisition Corp. II	0 of 5 stars 0.00 / 5 stars	$0.08 flat	N/A	N/A	$0.00	N/A	0.00	4	Positive News
SUBL BioLingus (Cayman)	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	N/A	0.00	N/A	High Trading Volume
SAVAW Cassava Sciences	0 of 5 stars 0.00 / 5 stars	$0.03 flat	N/A	N/A	$0.00	N/A	0.00	30	Gap Up
FBIOP Fortress Biotech	0 of 5 stars 0.00 / 5 stars	$8.75 -1.0%	N/A	-47.6%	$0.00	$85.11M	0.00	170	Short Interest ↓ News Coverage
LIXTW Lixte Biotechnology	0 of 5 stars 0.00 / 5 stars	$0.07 +15.4%	N/A	-29.4%	$0.00	N/A	0.00	4	Gap Up
MYNZ Mainz Biomed	1.6469 of 5 stars 1.65 / 5 stars	$0.36 +2.9%	$6.00 +1,566.7%	-92.4%	$0.00	$900,000.00	-0.22	30	Short Interest ↑ News Coverage Gap Up
NLSPW NLS Pharmaceutics	0 of 5 stars 0.00 / 5 stars	$0.04 flat	N/A	-55.5%	$0.00	N/A	0.00	6	Short Interest ↑
NLSP NLS Pharmaceutics	0 of 5 stars 0.00 / 5 stars	$0.20 +5.2%	N/A	-82.1%	$0.00	N/A	0.00	6	Short Interest ↓ News Coverage Positive News